Company Glycorex Transplantation AB

Equities

GTAB B

SE0000524530

Medical Equipment, Supplies & Distribution

End-of-day quote NORDIC GROWTH MARKET 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
1.07 SEK 0.00% Intraday chart for Glycorex Transplantation AB +30.49% -19.25%

Business Summary

Glycorex Transplantation publ AB is a Sweden-based medical device company engaged in the research, development, production and sales of medical devices within the field of organ transplantation. The Company's main product, Glycosorb-ABO, facilitates organ transplantation between different blood types. Additionally, the Company has developed complementary product variants, such as Glycosorb-ABO A/B-kolonn, designed for different patient categories, and Glycosorb-Xeno, which can facilitate transplants between animals and humans. As of December 31, 2011, Glycosorb-ABO was used in 103 transplantation centers in 22 countries. As of December 31, 2011, the Company had four wholly owned subsidiaries, namely Glycoprobe AB, Glycorex Transplantation, Glycorex UMC AB and Glycorex UBP AB.

Number of employees: 23

Sales per Business

SEK in Million2021Weight2022Weight Delta
Organ Transplantation
100.0 %
28 100.0 % 36 100.0 % +28.06%

Sales per region

SEK in Million2021Weight2022Weight Delta
Rest of Northern Europe
60.1 %
17 58.7 % 22 60.1 % +31.21%
Southern Europe
14.2 %
4 15.4 % 5 14.2 % +18.18%
Asia
13.6 %
3 11.1 % 5 13.6 % +57.44%
Oceania
5.5 %
1 3.8 % 2 5.5 % +89.13%
Sweden
4.9 %
3 10.1 % 2 4.9 % -38.67%
North America
0.9 %
0 1.0 % 0 0.9 % +18.12%
Other Countries
0.8 %
-- 0 0.8 % -

Managers

Managers TitleAgeSince
Chief Executive Officer 51 21-12-31
Founder 71 95-12-31
Sales & Marketing - 22-03-31
Comptroller/Controller/Auditor - 19-12-31

Members of the board

Members of the board TitleAgeSince
Founder 71 95-12-31
Chairman 71 99-12-31
Director/Board Member 72 22-12-31
Chief Executive Officer 51 21-12-31
Director/Board Member 62 20-12-31
Director/Board Member 64 20-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 10 3,268,000 0 0 95.58 %
Stock B 1 70,585,983 70,585,983 ( 100.00 %) 0

Shareholders

NameEquities%Valuation
5,236,444 7.419 % 416 245 kr
Glycorex AB
5.035 %
3,554,118 5.035 % 282 517 kr
Henningson Affärsfastigheter AB
3.008 %
2,122,945 3.008 % 168 753 kr
Skandia Fonder AB
2.118 %
1,495,165 2.118 % 118 851 kr
1,493,648 2.116 % 118 730 kr
1,266,639 1.794 % 100 685 kr
Alfred Berg Kapitalförvaltning AB
1.628 %
1,149,046 1.628 % 91 338 kr
1,108,967 1.571 % 88 152 kr
1,071,230 1.518 % 85 152 kr
Coeli Asset Management AB
1.049 %
740,480 1.049 % 58 861 kr
NameEquities%Valuation
1,866,000 57.10 % 3 M kr
Glycorex AB
42.90 %
1,402,000 42.90 % 2 M kr

Company contact information

Glycorex Transplantation AB

Scheelevägen 27

223 63, Lund

+46 4 62 86 52 30

http://www.glycorex.se
address Glycorex Transplantation AB(GTAB B)
  1. Stock Market
  2. Equities
  3. GTAB B Stock
  4. Company Glycorex Transplantation AB